Nebius Group NV vs Twist Bioscience Corp — how do they compare? Nebius Group NV trades at $217.31 (market cap $49.06B), while Twist Bioscience Corp trades at $125.69 (market cap $7.72B). The key difference: Nebius Group NV is far larger — about 6.4× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Nebius Group NV nearer its low. Which is the better fit depends on your goals.
| NBIS | TWST | |
|---|---|---|
Market Cap | $49.06B | $7.72B |
Sector | Technology | Health |
52-Week High | $286.69 | $124.88 |
52-Week Low | $64.06 | $24.16 |
Enterprise Value | $49.26B | $7.65B |
Trailing returns across standard periods
Latest headlines on both assets
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →